🟢 GT Biopharma is trading 8.85% up in pre-market

GT Biopharma is trading at $6.64, up 8.85% in pre-market; no clear catalyst has been identified.

• No new company-specific announcement for October 5 was identified; the latest located release, dated September 15, concerned a potential new indication for GTB-5550.
• The supplied broader-market snapshot was slightly lower, offering no clear explanation for the move.
• A prior after-hours note also reported a rise without an identified catalyst; recent GTB-5550 news does not establish causation.